影像学结外延伸预示cN+ TNM-8 I期人乳头瘤病毒相关口咽癌结局更差
本研究纳入2008至2015年接受根治性调强放疗的HPV+ cT1-T2cN1口咽癌患者,由头颈神经放射科医师评估影像学淋巴结特征。rENE+组5年远处控制率和无病生存率均低于rENE-组,多因素分析显示rENE+是无病生存的独立预后因素。
要点
- rENE+组5年无病生存率58% vs rENE-组90%,P < .001。
- rENE+组5年远处控制率78% vs rENE-组95%,P < .001。
- 多因素分析rENE+对无病生存的HR为4.3(95%CI 2.3-8.1),P < .001。
核心结论
- 来自同期治疗的cT1-T2N1 HPV+口咽癌队列的数据提示,rENE的存在是I期HPV+口咽癌内的独立预后因素。
- RPLN也与远处转移风险相关,但与无病生存无关。
研究设计与样本
- 纳入2008至2015年接受根治性调强放疗的所有HPV+ cT1-T2cN1口咽癌患者。
- 由专门的头颈神经放射科医师在治疗前计算机断层扫描/磁共振成像上评估影像学受累淋巴结数量、rENE、RPLN和下颈部(4区或5b区)淋巴结受累。
- 比较rENE+与rENE-患者之间的无病生存、局部区域控制和远处控制。
- 应用单变量和多变量分析及逐步模型选择来确定无病生存的预后因素。
主要发现
- 共识别45例rENE+和234例rENE-患者。
- rENE+队列每例患者淋巴结数量更多(中位数:6 vs 2,P < .001),且更可能有坏死淋巴结(33例[73%] vs 132例[56%],P = .046)。
- 中位随访时间为4.8年。
- 两队列局部区域控制率均较高(93% vs 97%,P = .34),但rENE+组5年远处控制率较差(78%[59-88] vs 95%[91-97],P < .001),无病生存率也较差(58%[43-77] vs 90%[86-94],P < .001)。
- 多变量分析中,rENE+(HR 4.3[2.3-8.1],P < .001)、T2(vs T1)分类(HR 2.1[1.0-4.2],P = .039)、吸烟包年(HR 1.02[1.0-1.03],P = .013)和添加全身药物(HR 0.4[0.2-0.8],P = .005)是无病生存的预后因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify adverse radiologic nodal features in cN+ TNM-8 stage I human papillomavirus-related (HPV+) oropharyngeal cancer (OPC). METHODS AND MATERIALS: All patients with HPV+ cT1-T2cN1 OPC treated with definitive intensity modulated radiation therapy from 2008 to 2015 were included. Radiologically involved lymph node number (LN), radiologic extranodal extension (rENE), retropharyngeal LN (RPLN), and lower neck (level 4 or 5b) LN involvement were assessed on pre-treatment computed tomography/magnetic resonance imaging by a specialized head and neck neuroradiologist. Disease-free survival (DFS), locoregional control, and distant control were compared between those with versus without rENE. Univariable and multivariable analysis with stepwise modal selection were applied to identify prognostic factors for DFS. RESULTS: A total of 45 rENE+ and 234 rENE- were identified. The rENE+ cohort had a higher number of LNs per patient (median: 6 vs 2, P < .001) and was more likely to have necrotic LNs (33 [73%] vs 132 [56%], P = .046). Median follow-up was 4.8 years. Although locoregional control was high in both cohorts (93% vs 97%, P = .34), the rENE+ group had inferior 5-year distant control (78% [59-88] vs 95% [91-97], P < .001) and DFS (58% [43-77] vs 90% [86-94], P < .001). In multivariable analysis, rENE+ (HR [hazard ratio] 4.3 [2.3-8.1], P < .001], T2 (vs T1) category (HR 2.1 [1.0-4.2], P = .039), smoking pack-years (HR 1.02 [1.0-1.03], P = .013), and the addition of systemic agents (HR 0.4 [0.2-0.8], P = .005) were prognostic for DFS. RPLN was prognostic for distant metastasis (HR 3.2, P = .013) but not for DFS after adjusting for rENE. CONCLUSIONS: Data from this contemporaneously treated cT1-T2N1 HPV+ OPC cohort suggest that the presence of rENE is an independent prognostic factor within stage I HPV+ OPC. RPLN is also associated with DM risk but not with DFS.
引用
- Billfalk-Kelly A, Yu E, Su J, et al. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 30953712. doi:10.1016/j.ijrobp.2019.03.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。